i don't see it
huh? where are you getting this from? making stuff up?
at these levels, given the recent news, the diverse pipeline and prospects moving forward, i would have to think this is very cheap at these levels
the recent results didn't change anything for the company? seemed positive to me given the current small market cap
lol, yeah, sure
ummm, you're really grasping at straws. fda will not approve. sorry fella
you can say that for almost every biotech